PANDION THERAPEUTICS, INC. Share-based Payment Arrangement, Expense
PANDION THERAPEUTICS, INC. reported Share-based Payment Arrangement, Expense of $2.65 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-12.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2021-03-12
- PANDION THERAPEUTICS, INC. share-based payment arrangement, expense for the quarter ending 2020-12-31 was $1.11M, a 1719.67% increase year-over-year.
- PANDION THERAPEUTICS, INC. share-based payment arrangement, expense for the quarter ending 2020-09-30 was $1.33M, a 3217.50% increase year-over-year.
- PANDION THERAPEUTICS, INC. share-based payment arrangement, expense for the quarter ending 2020-06-30 was $150.00K, a 1263.64% increase year-over-year.
- PANDION THERAPEUTICS, INC. share-based payment arrangement, expense for the quarter ending 2020-03-31 was $60.00K.
- PANDION THERAPEUTICS, INC. share-based payment arrangement, expense for fiscal 2020 was $2.65M, a 2105.83% increase from fiscal 2019.
- PANDION THERAPEUTICS, INC. share-based payment arrangement, expense for fiscal 2019 was $120.00K.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|
| 2020-12-31 | $1.11M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $2.44M derived: sum of 2 quarters · filed 2021-03-12 | $2.59M derived: sum of 3 quarters · filed 2021-03-12 | $2.65M 10-K · filed 2021-03-12 |
| 2020-09-30 | $1.33M 10-Q · filed 2020-11-16 | $1.48M derived: sum of 2 quarters · filed 2020-11-16 | $1.54M 10-Q · filed 2020-11-16 | $1.60M derived: sum of 4 quarters · filed 2021-03-12 |
| 2020-06-30 | $150.00K 10-Q · filed 2020-08-31 | $210.00K 10-Q · filed 2020-08-31 | $271.00K derived: sum of 3 quarters · filed 2021-03-12 | $311.00K derived: sum of 4 quarters · filed 2021-03-12 |
| 2020-03-31 | $60.00K derived: 10-K 12 month − 3 quarters · filed 2021-03-12 | $121.00K derived: sum of 2 quarters · filed 2021-03-12 | $161.00K derived: sum of 3 quarters · filed 2021-03-12 | $172.00K derived: sum of 4 quarters · filed 2021-03-12 |
| 2019-12-31 | $61.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $101.00K derived: sum of 2 quarters · filed 2021-03-12 | $112.00K derived: sum of 3 quarters · filed 2021-03-12 | $120.00K 10-K · filed 2021-03-12 |
| 2019-09-30 | $40.00K 10-Q · filed 2020-11-16 | $51.00K derived: sum of 2 quarters · filed 2020-11-16 | $59.00K 10-Q · filed 2020-11-16 | |
| 2019-06-30 | $11.00K 10-Q · filed 2020-08-31 | $20.00K 10-Q · filed 2020-08-31 |